HER2 testing in gastric cancer: An update

doi:10.3748/wjg.v22.i19.4619

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (22780)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

1679

WORD

266

HTML

16951

Figures (1-4)

537

Tables (1-2)

227

Sum=19660

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1260

Download

1860

Sum=3120

May 21, 2016 (publication date) through Dec 30, 2024

Times Cited of This Article

Times Cited (203)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. May 21, 2016; 22(19): 4619-4625
Published online May 21, 2016. doi: 10.3748/wjg.v22.i19.4619

Full Size Figure Download Figure

Figure 3 Representative image of the intratumoral heterogeneity of HER2 expression. Arrows indicate areas with strong continuous membranous staining (score 3+) and arrowheads indicate negative areas (score 0) (× 100). HER2: Human epidermal growth factor receptor 2.

Citation: Abrahao-Machado LF, Scapulatempo-Neto C. HER2 testing in gastric cancer: An update. World J Gastroenterol 2016; 22(19): 4619-4625
URL: https://www.wjgnet.com/1007-9327/full/v22/i19/4619.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i19.4619